Affordable Access

Itraconazole versus griseofulvine in the treatment of tinea corporis and tinea cruris.

Authors
  • Acharya, K M
  • Mukhopadhyay, A
  • Thakur, R K
  • Mehta, T
  • Bhuptani, N
  • Patel, R
Type
Published Article
Journal
Indian Journal of Dermatology Venereology and Leprology
Publisher
Medknow Publications
Publication Date
Jan 01, 1995
Volume
61
Issue
4
Pages
209–211
Identifiers
PMID: 20952956
Source
Medline
License
Unknown

Abstract

126 patients (82 males and 44 females) aged above 12 years, suffering from tinea corporis and/or tinea cruris, were treated with either itraconazole (100 mg once a day for 2 weeks and then plecebo for 2 weeks) (63 patients), or griseofulvin (250 mg twice a day for 4 weeks). 90.47% of the patients treated with itraconzole improved whereas griseofulvin imporved 76.19% of patients, clinically. Mycological response was 72% with itraconazole and 57% with griseofulvin.

Report this publication

Statistics

Seen <100 times